Zhongxin innovative drug R & D department is composed of several high-quality R & D personnel with many years of experience in drug development; And it has complete experimental facilities; Relying on the public platform for drug research and development of Kangyuan group, the team has the direct right to use a number of large-scale instruments, including BMG pherastar, MD high content screening instrument, FLIPR, BD sorting flow cytometer, etc., which can meet the flexible detection requirements in the research and development of new biological drugs.

　　Zhongxin innovative drug R & D department is mainly responsible for the research on the biological activity, toxicity and in vitro mechanism of candidate drugs, so as to ensure the normal progress of the company's new drug R & D.

　　At present, the specific experiments that the innovative drug R & D Department of the company can carry out are as follows: